Journal
ELIFE
Volume 6, Issue -, Pages -Publisher
ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.21615
Keywords
-
Categories
Funding
- Cancer Research UK [21143] Funding Source: researchfish
- NCI NIH HHS [P01 CA129243, P30 CA045508] Funding Source: Medline
- NIGMS NIH HHS [T32 GM065094] Funding Source: Medline
Ask authors/readers for more resources
Many lines of evidence have indicated that both genetic and non-genetic determinants can contribute to intra-tumor heterogeneity and influence cancer outcomes. Among the best described sub-population of cancer cells generated by non-genetic mechanisms are cells characterized by a CD44+/CD24 cell surface marker profile. Here, we report that human CD44+/CD24 cancer cells are genetically highly unstable because of intrinsic defects in their DNA-repair capabilities. In fact, in CD44+/CD24 cells, constitutive activation of the TGF-beta axis was both necessary and sufficient to reduce the expression of genes that are crucial in coordinating DNA damage repair mechanisms. Consequently, we observed that cancer cells that reside in a CD44+/ CD24 state are characterized by increased accumulation of DNA copy number alterations, greater genetic diversity and improved adaptability to drug treatment. Together, these data suggest that the transition into a CD44+/CD24 cell state can promote intra-tumor genetic heterogeneity, spur tumor evolution and increase tumor fitness.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available